Targeted approaches to cancer therapy.
Magrath
I T
IT
Lymphoma Biology Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D004353:Drug Evaluation, Preclinical; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy
D000970:Antineoplastic Agents